Literature DB >> 33565158

Regulation of Chlamydia spreading from the small intestine to the large intestine via an immunological barrier.

Conghui He1,2, Ying Xu1,3, Zhi Huo1,3, Jie Wang3, Tianjun Jia2, Xiao-Dong Li1, Guangming Zhong1.   

Abstract

The obligate intracellular bacterium Chlamydia is a genital tract pathogen that can also colonize the gastrointestinal tract for long periods. The long-lasting colonization is dependent on chlamydial spreading from the small intestine to the large intestine. We previously reported that a mutant Chlamydia was able to activate an intestinal barrier for blocking its own spreading to the large intestine. In the current study, we used the mutant Chlamydia colonization model to confirm the intestinal barrier function and further to determine the immunological basis of the barrier with gene-deficient mice. Recombination activating gene 1-/- mice failed to block the mutant Chlamydia spreading, while mice deficient in toll-like receptors, myeloid differentiation primary response 88 or stimulator of interferon genes still blocked the spreading, suggesting that the intestinal barrier function is dependent on lymphocytes that express antigen receptors. Mice deficient in CD4, but not CD8 nor μ chain failed to prevent the chlamydial spreading, indicating a protective role of CD4+ cells in the intestinal barrier. Consistently, adoptive transfer of CD4+ T cells reconstituted the intestinal barrier in CD4-/- mice. More importantly, CD4+ but not CD8+ T cells nor B cells restored the intestinal barrier function in recombination activating gene 1-/- mice. Thus, CD4+ T cells are necessary and sufficient for maintaining the intestinal barrier function, indicating that the spread of an intracellular bacterium from the small intestine to the large intestine is regulated by an immunological barrier. This study has also laid a foundation for further illuminating the mechanisms by which a CD4+ T cell-dependent intestinal barrier regulates bacterial spreading in the gut.
© 2021 Australian and New Zealand Society for Immunology Inc.

Entities:  

Keywords:  zzm321990Chlamydiazzm321990; CD4+ T cells; intestinal barrier

Year:  2021        PMID: 33565158     DOI: 10.1111/imcb.12446

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  4 in total

1.  Lactobacillus Modulates Chlamydia Infectivity and Genital Tract Pathology in vitro and in vivo.

Authors:  Hongliang Chen; Shuling Min; Li Wang; Lanhua Zhao; Fangzhen Luo; Wenbo Lei; Yating Wen; Lipei Luo; Qianting Zhou; Lixiu Peng; Zhongyu Li
Journal:  Front Microbiol       Date:  2022-04-28       Impact factor: 6.064

Review 2.  Chlamydia overcomes multiple gastrointestinal barriers to achieve long-lasting colonization.

Authors:  Guangming Zhong
Journal:  Trends Microbiol       Date:  2021-04-14       Impact factor: 17.079

3.  Chlamydia Deficient in Plasmid-Encoded Glycoprotein 3 (pGP3) as an Attenuated Live Oral Vaccine.

Authors:  Zengzi Zhou; Qi Tian; Luying Wang; Guangming Zhong
Journal:  Infect Immun       Date:  2022-01-31       Impact factor: 3.609

4.  Gastrointestinal Chlamydia-Induced CD8+ T Cells Promote Chlamydial Pathogenicity in the Female Upper Genital Tract.

Authors:  Qi Tian; Zengzi Zhou; Luying Wang; Xin Sun; Bernard Arulanandam; Dabao Xu; Min Xue; Guangming Zhong
Journal:  Infect Immun       Date:  2021-07-06       Impact factor: 3.441

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.